The newly released 2025 asthma guidelines from the VA and DOD offer a modern framework for managing respiratory health. This update reflects the latest evidence gathered between 2018 and 2024. Consequently, healthcare providers must now prioritize inhaled corticosteroids (ICS) to reduce inflammation. The guidelines emphasize a streamlined approach for both veterans and military personnel. By adopting these standards, clinicians can significantly improve patient outcomes and quality of life.
Implementing the 2025 Asthma Guidelines in Primary Care
The primary change involves the adoption of combination therapy as the first-line defense. Specifically, the working group suggests using a single inhaler for both maintenance and rescue needs. This method, often called SMART or MART therapy, utilizes a fast-onset long-acting \u03b2-agonist (LABA) paired with an ICS. Furthermore, clinicians should consider stepping up therapy by adding long-acting anticholinergic agents when symptoms persist. This streamlined strategy simplifies daily regimens and ensures patients receive anti-inflammatory medication during acute episodes.
Addressing Comorbidities and Environmental Factors
Effective management extends beyond pharmacology. For instance, the guidelines strongly support treating symptomatic gastroesophageal reflux disease (GERD) and obesity. Because these conditions exacerbate airway hyperresponsiveness, their control is vital for respiratory stability. Interestingly, the updated recommendations suggest against the use of indoor air filtration devices. Instead, the focus remains on personal medical management and evidence-based clinical interventions. If patients fail to respond to standard primary care, clear decision points now exist for subspecialist referral.
Frequently Asked Questions
Q1: Does the 2025 update support the use of indoor air filters?
No, the current guidelines suggest against the use of indoor air filtration devices for managing asthma symptoms.
Q2: What is the recommended reliever therapy for military members?
The guidelines suggest using a combination of an inhaled corticosteroid and a rapid-onset long-acting beta-agonist as both a reliever and a controller.
Q3: When should a primary care provider refer a patient to a subspecialist?
Refer your patient when asthma remains uncontrolled despite step-up therapy or when you require specific diagnostic clarification.
References
- Sharafkhaneh A et al. A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Asthma. Ann Intern Med. 2026 Feb 17. doi: 10.7326/ANNALS-25-03080. PMID: 41698207.
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2025.
- U.S. Department of Veterans Affairs. VA/DOD Clinical Practice Guideline for the Primary Care Management of Asthma: Provider Summary. 2025.